BLOOD BASED BIOMARKER MARKET ANALYSIS

Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Feb 2022
Code : CMI4945
Pages :166
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Global Blood Based Biomarkers Market: Restraint

The major factors that hinder growth of the global blood based biomarkers market include issues related to regulatory and reimbursement systems. According to data published by Blue Cross and Blue Shield Association in January 2019, the reimbursement for Alzheimer's disease is not provided by most of the insurance providers, such as the Blue Cross and Blue Shield Association. The reimbursement coverage for neurological biomarker testing in emerging economies, such as India and China, is even lesser, as these countries have low insurance penetration and very little awareness about biomarker testing.